Forward Look The Impact of HPV Vaccination Over a decade after human papillomavirus vaccines first became available in the U.S., their effect on cervical cancer incidence is becoming apparent. by Carisa D. Brewster Genetic Testing Gaps Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling. by Kate Yandell Forward Look What’s Next A therapeutic vaccine targeting advanced cervical cancer. by Anna Azvolinsky Cervical Cancer Screening Guideline Updated A new version of the American Cancer Society’s cervical cancer screening guideline says screening can start at a later age and highlights human papillomavirus testing as the preferred method. by Anna Azvolinsky Survivor Profile Sharing Her Strength Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer. by Lindsey Konkel FROM THE EDITOR-IN-CHIEF Human Papillomavirus Vaccines: Bad News, Good News and Great News Increased vaccination rates can help reduce cervical cancer as a worldwide health threat. by William G. Nelson, MD, PhD BRCA: Who Should Be Tested? Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out. by Sue Rochman Our Own Words People with cancer and their loved ones find ways for their voices to be heard without filters. by Bradley Jones Finding Support in Unlikely Places After her diagnosis with ovarian cancer, Patricia Anne Ward noticed that some friends and family pulled away. She found connection outside her usual circles. by Patricia Anne Ward Why Is the Rate of Uterine Cancer Rising? Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed. by Ashley P. Taylor next Cancer Talk Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Open Medical Records: Pros and Cons Patients now have full access to their online medical records. What are the benefits and downsides? by Jen Tota McGivney Remote Care After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment. by Jon Kelvey Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks More Posts